Medigen Biotechnology Corp.

Medigen Biotechnology Corp.verified

3176.TWO

Price:

$30.5

Market Cap:

$4.25B

Medigen Biotechnology Corp., a biopharmaceutical company, focuses on the development of therapies for liver diseases and cancers in Taiwan. It offers cell therapies, such as MAGICELL-NK, which are natural killer cells; and MAGICELL-GDT, which are T cells. It also develops OBP-301 that has completed Phase I clinical trials in combination with esophageal cancer in Japan; is in Phase I clinical trials in combination with immune checkpoint inhibitors (ICI) for patients with esophageal cancer in Japan; and in phase II study in combination with ICI for esophageal cancer and gastric cancer patients in the United States. Medigen Biotechnology Corp. was founded in 1999 and is headquartered in Taipei,...[Read more]

Industry

Biotechnology

IPO Date

2007-12-31

Stock Exchange

TWO

Ticker

3176.TWO

The Current Ratio as of December 2025 (TTM) for Medigen Biotechnology Corp. (3176.TWO) is 4.43

According to Medigen Biotechnology Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 4.43. This represents a change of 3.31% compared to the average of 4.29 of the last 4 quarters.

Medigen Biotechnology Corp. (3176.TWO) Historical Current Ratio (quarterly & annually)

How has 3176.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Medigen Biotechnology Corp. over the last ten years is 3.17. The current 4.43 Current Ratio has changed 13.88% with respect to the historical average. Over the past ten years (40 quarters), 3176.TWO's Current Ratio was at its highest in in the September 2022 quarter at 8.66. The Current Ratio was at its lowest in in the March 2024 quarter at 1.97.

Quarterly (TTM)
Annual

Average

3.17

Median

2.47

Minimum

1.41

Maximum

6.40

Medigen Biotechnology Corp. (3176.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Medigen Biotechnology Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 129.46%

Maximum Annual Current Ratio = 6.40

Minimum Annual Increase = -67.91%

Minimum Annual Current Ratio = 1.41

Quarterly (TTM)
Annual
YearCurrent RatioChange
20243.9692.71%
20232.05-67.91%
20226.4038.53%
20214.6242.73%
20203.24129.46%
20191.41-39.75%
20182.3414.94%
20172.04-17.66%

Medigen Biotechnology Corp. (3176.TWO) Average Current Ratio

How has 3176.TWO Current Ratio performed in the past?

The current Current Ratio of Medigen Biotechnology Corp. (3176.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.14

5-year avg

4.05

10-year avg

3.17

Medigen Biotechnology Corp. (3176.TWO) Current Ratio vs. Peers

How is 3176.TWO’s Current Ratio compared to its peers?

Medigen Biotechnology Corp.’s Current Ratio is less than Senhwa Biosciences, Inc. (38.38), less than UnicoCell Biomed Co., Ltd. (35.10), less than BRIM Biotechnology, Inc. (5.18), less than Energenesis Biomedical CO.,LTD. (43.35), less than Formosa Pharmaceuticals, Inc. (9.85), less than AnnJi (4.99), greater than TWi Biotechnology, Inc. (2.78), greater than Synbio Tech Inc. (1.64), less than Shine-On BioMedical Co.,Ltd. (115.08), less than Sagittarius Life Science Corp (10.89),

Build a custom stock screener for Medigen Biotechnology Corp. (3176.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Biotechnology Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medigen Biotechnology Corp. (3176.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medigen Biotechnology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Medigen Biotechnology Corp.'s Current Ratio?

How is the Current Ratio calculated for Medigen Biotechnology Corp. (3176.TWO)?

What is the highest Current Ratio for Medigen Biotechnology Corp. (3176.TWO)?

What is the 3-year average Current Ratio for Medigen Biotechnology Corp. (3176.TWO)?

What is the 5-year average Current Ratio for Medigen Biotechnology Corp. (3176.TWO)?

How does the current Current Ratio for Medigen Biotechnology Corp. (3176.TWO) compare to its historical average?